Articles related to Oncology, Medical

Osimertinib significantly improved progression-free survival in patients with unresectable stage III EGFR-mutant NSCLC after chemoradiotherapy, with a hazard ratio of 0.16 compared to placebo.

Intramuscular fat accumulation poses a significant mortality risk, potentially surpassing that of obesity and muscle wasting, according to recent research.

The I-SPY2 trial demonstrates that novel treatment approaches can yield high pathologic complete response rates in rare histologic subtypes of high-risk breast cancer, potentially improving outcomes for these challenging cases.

Nearly 70% of 340B contract pharmacies are now associated with pharmacy benefit managers, potentially shifting the program’s focus away from its original intent of supporting safety-net providers.

The loss of two oncology residents in a plane crash has left a significant void in cancer care at a major oncology center in Paraná, Brazil, highlighting the critical role of specialized medical professionals in smaller communities.

Financial pressures and staffing shortages are creating a challenging environment for oncology care, particularly in community hospitals.